MDA Share Price | MedApp SA Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare MedApp SA with Similar Stocks

Suntech SA Forever Entertainment SA Starward Industries SA

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Poor long term growth as Operating profit has grown by an annual rate -189.10% of over the last 5 years

Risky -

Mojo Parameters

Stock DNA

Industry

Software Products

Market cap

PLN 85 Million (Small Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.06

Return on Equity

-6.83%

Price to Book

3.55

Revenue and Profits:

Net Sales:

1 Million

(Quarterly Results - Dec 2025)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

16.11%

6 Months

21.87%

1 Year

-34.89%

2 Years

-49.39%

3 Years

-56.09%

4 Years

-78.23%

5 Years

-73.88%

MedApp SA for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

1.28%

EBIT Growth (5y)

-189.10%

EBIT to Interest (avg)

0.83

Debt to EBITDA (avg)

0.31

Net Debt to Equity (avg)

0.05

Sales to Capital Employed (avg)

0.23

Tax Ratio

2.30%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

7.13%

ROE (avg)

7.53%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.63

EV to EBIT

-41.72

EV to EBITDA

20.00

EV to Capital Employed

1.60

EV to Sales

6.74

PEG Ratio

Dividend Yield

ROCE (Latest)

-3.79%

ROE (Latest)

-3.08%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bearish

Bollinger Bands

Sideways

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 0.00% vs -38.46% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 87.50% vs -60.00% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.80",
          "val2": "0.80",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.20",
          "val2": "-0.10",
          "chgp": "1,300.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.10",
          "val2": "-0.80",
          "chgp": "87.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1,118.70%",
          "val2": "-1,099.50%",
          "chgp": "221.82%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -47.22% vs 26.32% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -195.24% vs 167.74% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.80",
          "val2": "7.20",
          "chgp": "-47.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.20",
          "val2": "5.90",
          "chgp": "-79.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.10",
          "chgp": "500.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.00",
          "val2": "2.10",
          "chgp": "-195.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-284.30%",
          "val2": "347.40%",
          "chgp": "-63.17%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Jun'25

Change(%)

Net Sales

0.80

Operating Profit (PBDIT) excl Other Income

1.20

-0.10

1,300.00%

Interest

0.60

0.00

Exceptional Items

0.00

Consolidate Net Profit

-0.10

-0.80

87.50%

Operating Profit Margin (Excl OI)

1,118.70%

-1,099.50%

221.82%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 0.00% vs -38.46% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 87.50% vs -60.00% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

3.80

7.20

-47.22%

Operating Profit (PBDIT) excl Other Income

1.20

5.90

-79.66%

Interest

0.60

0.10

500.00%

Exceptional Items

0.00

Consolidate Net Profit

-2.00

2.10

-195.24%

Operating Profit Margin (Excl OI)

-284.30%

347.40%

-63.17%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -47.22% vs 26.32% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -195.24% vs 167.74% in Dec 2024

All Annual Results

Company CV

About MedApp SA

MedApp SA

Software Products

Medapp SA is a Poland-based company engaged in the software development. The Company provides a software application, named Carna Life, which is used in telemedicine sector. Carna Life serves as communication channel between doctors and patient. Carna Life is a telemedicine system that enables patients to upload test results and receive doctor's interpretation. The application operates in online (upload and download of data) and offline (review of data) mode. Carna Life provides statistics, graphic visualizations and tables with interpreted data. The Company is controlled by Moonrock Enterprise SA.

Company Coordinates

Company Details

Longinusa Podbipiety 29 , KRAKOW None : 31-517

Tel: 48 22 8455555

http://www.medapp.pl/

Registrar Details